LSD
Ethereum staking narrative picks up as Lido DAO surges
Post Shapella, Ethereum staking is having another strong moment. Consequently, liquid staking protocols, such as Lido DAO, are faring well. … Read More
The…
Ethereum staking – the network-validation and passive-yield-earning system that’s core to functionality of the major smart-contracts-enabling blockchain – is having another moment right now. In a good way.
And what do we mean by that convoluted opening sentence?
We mean that stakers of ETH are currently enjoying their highest level of returns since the leading layer 1 blockchain completed its major “Shapella” upgrade in mid April, merging its tech from a “Proof of Work” mining system to Proof of Stake.
And how do we know this?
The “token unlocks schedule and intense tokenomics data” platform Token Unlocks tells us so. Here’s a very nice, very colourful, very clear chart…
Never mind the choppy price of ETH so much. While that’s obviously of importance to holders, it’s the sharp increase in ETH validators (green) and the staking APR (purple) this month that’s of most interest.
That APR has now reached a near-high of 8.73% at the time of writing, which would be a pretty impressive rate of return on staking yields if it were to remain around this level.
Why is this happening?
As mentioned, it’s the Ethereum upgrade, Shapella, innit. It’s allowed the unlocking of billions of dollars’ worth of ETH, which some speculated might be a potentially bearish event for the price of the token.
And while the price of ETH has been ranging below US$2k since a bit beyond that event, what the network upgrade has seemed to have done, however, is breathe new confidence into the crypto project.
“Watching Ethereum take the Shapella update in its stride is a big proof point towards its long-term success,” noted the Kraken exchange in an article for Stockhead the other day.
LIDO DAO and other staking services benefit
The price of liquid staking derivative (LSD) protocols are doing well today. Well, at least, the market leader Lido DAO certainly is.
The LDO token is currently leading the gainers in the top 100 cryptos by market cap, with a 7% 24-hour rise, and about a 16% surge overall across the past seven days.
Its nearest competitor, Rocket Pool (RPL), has also been faring well, with an 8% gain over the past week, while Frax Shares (FXS) is beginning to see a daily surge at the time of writing, too (+3%).
You can learn a bit more about liquid staking in this Apollo’s Alpha article from earlier this year. But part of the reason these protocols are seeing some gains, is at least one advantage they have over the staking of ETH on the blockchain’s mainnet.
And that’s the fact that mainnet staking requires a minimum deposit of 32 ETH, which, at about US$58k, is a very hefty sum indeed for the average investor – and out of range for many.
Lido and other protocols like it, don’t require anything like that as a minimum ETH deposit. In fact, on Lido, you can stake with any amount of ETH, while Rocket Pool is similar, providing its service for a deposit as low as 0.01 ETH.
At the time of writing, per Dune Analytics data, Lido Finance is still the leading LSD protocol, with its amount of staked ETH increasing by 9.87% over the past 30 days.
The post Ethereum staking narrative picks up as Lido DAO surges appeared first on Stockhead.
lsd shares-
Psychedelics1 week ago
Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Clinical Study of Bucillamine to Treat Long COVID
-
Psychedelics1 week ago
Algernon NeuroScience and the Centre for Human Drug Research to Present DMT Phase 1 Stroke Clinical Data at the Interdisciplinary Conference on Psychedelic Research June 6 – 8th, 2024
-
Law & Regulation1 week ago
Tryp Therapeutics merger with Exopharm approved by shareholders
-
Psilocybin1 week ago
Passover Perspectives: Psychedelics, Moses, and the Burning Bush
-
Psychedelics1 week ago
atai Life Sciences Announces Dosing of First Patient in Part 2 of Beckley Psytech’s Phase 2a Study Exploring BPL-003 Adjunctive to SSRIs in Patients with Treatment Resistant Depression
-
Psychedelics1 week ago
Silo Pharma Announces Positive Results for Intranasal PTSD Treatment
-
Psilocybin1 week ago
Psilocybin and Meditation: Unlocking the Potential for Enhancing Insightfulness
-
Psychedelics1 week ago
Silo Pharma Announces Positive Results for Intranasal PTSD Treatment